The Annual Report to the Nation on the Status of Cancer was released on May 22, 2018. The first part of the report focused on national cancer statistics. The report found that cancer mortality rates for men, women, and children continue to decline. In addition, The overall cancer incidence rate for children under age 14 increased, with variance by racial/ethnic group. Male  cancer incidence rates continue to decrease, with prostate cancer showing the greatest decrease. Cancer incidence rates in women  remained stable, with colorectal cancer showing the greatest decrease. Liver cancer showed the greatest increase in both men and women; this may be attributed to rising obesity rates. The rate of new lung cancer cases continues to decrease for both men and women as does the smoking rate, but lung cancer is still the second most common cancer for both men and women. 

The second part of the report focused on trends in prostate cancer rates of deaths and new cases in relation to changes in prostate-specific antigen (PSA) screening rates. The report found that after years of significant decline, the death rate trend for prostate cancer stabilized from 2013 to 2015, and the incidence of distant-stage prostate cancer increased from 2010-2014. The report also found that after a decline in PSA test usage, there is an increase in late-stage prostate cancer, and the decline in prostate cancer death rates has leveled off. 

Spring is here, and it's time to start building momentum for VeloSano 5! Remember, a ll of the funds raised through VeloSano support cancer research right here in Cleveland. 

Getting involved is easy. Your help and support is appreciated:

• Join Team Case CCC as a rider from the 12 to 200-mile level. Case CCC Director, Dr. Stan Gerson, will be on the 100-mile route, and looks  forward to riding with you!
• Raise funds as a virtual rider  on Team Case CCC by signing up and supporting all of us!
• Join as a volunteer to help before and during the ride to keep us on track, hydrated and cheered on!

Contact Team Captains Mary Wright ( maw143@case.edu) or Caroline El Sanadi ( cee17@case.edu) with any questions! 

Jun 3, 2018 | Beachwood Place

Walk or run with the  Case CCC team at the Race for the Place , June 3, 2018. This great event helps The Gathering Place to offer services to anyone touched by cancer, no matter their economic situation. Anyone and everyone is welcome to join our team. If you can't make the Race in person, please consider making a donation to support our efforts. Hope to see you there! Questions: Contact Captain Gillian Irwin ( gmi@case.edu ). 

Lan Zhou, MD, PhD

Mediates immune-suppressive microenvironment in serrated pathway of colon carcinogenesis 

Cancers hit certain populations harder than others, and researcher Monica Webb Hooper, director of the Office of Cancer Disparities Research at the Case Comprehensive Cancer Center, wants to know why. 

Case Western Reserve University again will be working with Microsoft, this time on a project related to "quantum computing. Radiology professor and  Case Comprehensive Cancer Centermember  Mark Griswold and his team will work with quantum computing experts at Microsoft Quantum on the new collaboration. The goal will be to "improve the practical ways that MRI machines acquire information during scans," according to a news release.

The AACR Team Science Award has been established by the AACR and Eli Lilly and Company to acknowledge and catalyze the growing importance of interdisciplinary teams to the understanding of cancer and/or the translation of research discoveries into clinical cancer applications. Proactive interaction between academic and industry researchers is particularly crucial to continue progress and accelerate drug development.

The team selected to receive the Thirteenth AACR Team Science Award will collectively be awarded an honorarium of $50,000 and be recognized during the AACR Annual Meeting 2019 in Atlanta, Georgia, USA (March 30-April 3, 2019). The represented institutions will be cited at the AACR Annual Meeting for their leadership role in fostering team science in cancer research.

Pezcoller Foundation-American Association for Cancer Research International Award for Extraordinary Achievement in Cancer Research

Deadline: Sep 12, 2018

The prestigious Pezcoller Foundation-AACR International Award for Cancer Research was established in 1997 to annually recognize a scientist of international renown:

• who has made a major scientific discovery in basic cancer research OR who has made significant contributions to translational cancer research;
• who continues to be active in cancer research and has a record of recent, noteworthy publications; and
• whose ongoing work holds promise for continued substantive contributions to progress in the field of cancer.

The award is intended to honor an individual scientist. However, more than one scientist may be co-nominated and selected to share the award when their investigations are closely related in subject matter and have resulted in work that is worthy of the award.

The award consists of an unrestricted honorarium of €75,000, a commemorative plaque, and full support to the winner and a guest to attend the AACR Annual Meeting. The winner of the 22nd Annual Pezcoller Foundation-AACR International Award for Extraordinary Achievement Cancer Research will give an award lecture at the AACR Annual Meeting 2019 in Atlanta, Georgia, USA (March 30-April 3, 2019).